SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,598.04 17.50
( 0.02%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.73 0.08
(0.09%)

EUR-INR

109.20 -0.36
(-0.33%)

GBP-INR

127.12 -0.62
(-0.48%)

JPY-INR

0.61 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

139.64

444596.77

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.86

Back

ceat ltd

CEAT consolidated net profit declines 96.43% in the June 2026 quarter

Jul 17,2026

Net profit of CEAT declined 96.43% to Rs 4.00 crore in the quarter ended June 2026 as against Rs 112.00 crore during the previous quarter ended June 2025. Sales rose 22.36% to Rs 4318.00 crore in the quarter ended June 2026 as against Rs 3529.00 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	4318.00	3529.00	22
OPM %	8.45	10.97	-
PBDT	225.00	310.00	-27
PBT	39.00	159.00	-75
NP	4.00	112.00	-96

73,598.04 17.50 ( 0.02%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

66,308.10 794.11 (1.21%)

10,680.49 -24.77 (-0.23%)

95.73 0.08 (0.09%)

109.20 -0.36 (-0.33%)

127.12 -0.62 (-0.48%)

0.61 0.00 (-0.28%)